Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpheart.00831.2010PMID 21217072PMCID PMC3064303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries

  2009cited by this paper
• L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.

  2009cited by this paper
• Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity

  2008cited by this paper
• High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.

  2008cited by this paper
• ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION

  2007cited by this paper
• Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene.

  2006cited by this paper
• High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion.

  2006cited by this paper
• Increased Cyclooxygenase-2 Expression and Prostaglandin-Mediated Dilation in Coronary Arterioles of Patients With Diabetes Mellitus

  2006cited by this paper
• Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension

  2004cited by this paper
• PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes

  2004cited by this paper
• Endothelial function in coronary arterioles from pigs with early-stage coronary disease induced by high-fat, high-cholesterol diet: effect of exercise.

  2004cited by this paper
• Arginine and endothelial and vascular health.

  2004cited by this paper
• Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide–Mediated Dilation of Coronary Arterioles

  2004cited by this paper
• PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.

  2004cited by this paper
• Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes

  2003cited by this paper
• Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects.

  2003cited by this paper
• Lack of Nitric Oxide Mediation of Flow-Dependent Arteriolar Dilation in Type I Diabetes Is Restored by Sepiapterin

  2003cited by this paper
• Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans

  2001cited by this paper
• Anti-oxidants - a protective role in cardiovascular disease?

  2001cited by this paper
• Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats.

  2001cited by this paper
• Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial data

  2001cited by this paper
• Tetrahydrobiopterin biosynthesis, regeneration and functions.

  2000cited by this paper
• Endothelial dysfunction in diabetes

  2000cited by this paper
• Enhanced NO Inactivation and Hypertension Induced by a High-Fat, Refined-Carbohydrate Diet

  2000cited by this paper
• Effect of oral vitamin E (α‐tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus

  1999cited by this paper
• Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.

  1998cited by this paper
• Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects

  1998cited by this paper
• Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine.

  1998cited by this paper
• Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors.

  1998cited by this paper
• Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans.

  1998cited by this paper
• Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production.

  1997cited by this paper
• Endothelial dysfunction and pathogenesis of diabetic angiopathy.

  1997cited by this paper
• Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat

  1997cited by this paper
• Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

  1995cited by this paper
• Nitric oxide and its role in the cardiovascular system.

  1995cited by this paper
• Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function

  1993cited by this paper
• Pathophysiological dilemma of syndrome X.

  1992cited by this paper
• Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries.

  1992cited by this paper
• Regulatory functions of the vascular endothelium.

  1990cited by this paper

• Arginase 1 genetic variation is associated with the risk of vascular complications in type 2 diabetes.

  2025cites this paper
• l-Arginine: A multifaceted regulator of diabetic cardiomyopathy.

  2025cites this paper
• Citrulline Supplementation Improves Microvascular Function and Muscle Strength in Middle-Aged and Older Adults with Type 2 Diabetes

  2025cites this paper
• Biochemistry, pharmacology, and in vivo function of arginases

  2024cites this paper
• Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets

  2023cites this paper
• Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

  2023influential citation
• Chronic anemia is associated with systemic endothelial dysfunction

  2023cites this paper
• Association of cerebral microvascular dysfunction and white matter injury in Alzheimer’s disease

  2022cites this paper
• Elevated serum extracellular vesicle arginase 1 in type 2 diabetes mellitus: a cross-sectional study in middle-aged and elderly population

  2022cites this paper
• Role of Caveolae in the Development of Microvascular Dysfunction and Hyperglycemia in Type 2 Diabetes

  2022cites this paper
• Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective

  2022cites this paper
• Identifying medically relevant xenon protein targets by in silico screening of the structural proteome

  2022cites this paper
• Endothelial Nitric Oxide Synthase (eNOS) as a Therapeutic Target in Type 2 Diabetes Mellitus and Its Vascular Complications: A Narrative Review

  2022cites this paper
• Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2

  2022cites this paper
• Mechanisms and Clinical Implications of Endothelium-dependent Vasomotor Dysfunction in Coronary Microvasculature.

  2022cites this paper
• Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications

  2022influential citation
• Beyond eNOS: Genetic influence in NO pathway affecting drug response

  2022cites this paper
• Enhancing the Production of Therapeutic Enzyme Arginase from Lactobacillus acidophilus Using Response Surface Methodology

  2022cites this paper
• Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases

  2022cites this paper
• A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus

  2021cites this paper
• Development of a new nano arginase HPLC capillary column for the fast screening of arginase inhibitors and evaluation of their binding affinity.

  2021cites this paper
• Long lasting protective effects of early l-arginine treatment on endothelium in an in vitro study.

  2021cites this paper
• Endogenous flux of nitric oxide: Citrulline is preferred to Arginine

  2020cites this paper
• Endothelial Dysfunction: A Contributor to Adverse Cardiovascular Remodeling and Heart Failure Development in Type 2 Diabetes beyond Accelerated Atherogenesis

  2020cites this paper
• HuangqiGuizhiWuwu Decoction Prevents Vascular Dysfunction in Diabetes via Inhibition of Endothelial Arginase 1

  2020cites this paper
• Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?

  2020cites this paper
• Human-based evidence for the therapeutic potential of arginase inhibitors in cardiovascular diseases.

  2020cites this paper
• Improvement in endothelial function in cardiovascular disease - Is arginase the target?

  2019cites this paper
• Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arterioles.

  2019cites this paper
• Increased inflammation, oxidative stress and a reduction in antioxidant defense enzymes in perivascular adipose tissue contribute to vascular dysfunction in type 2 diabetes.

  2019cites this paper
• The role of arginase in aging: A systematic review.

  2019cites this paper
• Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation.

  2019cites this paper
• Deletion of endothelial arginase 1 does not improve vasomotor function in diabetic mice

  2018cites this paper
• Arginase: A Multifaceted Enzyme Important in Health and Disease.

  2018cites this paper
• Differential expression of genes identified by suppression subtractive hybridization in liver and adipose tissue of gerbils with diabetes

  2018cites this paper
• Vasodilator dysfunction and oligodendrocyte dysmaturation in aging white matter

  2018cites this paper
• ARG1 single nucleotide polymorphisms rs2781666 and rs2781665 confer risk of Type 2 diabetes mellitus

  2018cites this paper
• Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1

  2018cites this paper
• Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I.

  2018cites this paper
• Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes

  2018cites this paper
• Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

  2017cites this paper
• The importance of arginase for vascular dysfunction in patients with glucose and lipid abnormalities

  2017cites this paper
• l-Arginine Metabolism Impairment in Sepsis and Diseases: Causes and Consequences

  2017cites this paper
• Genetics of NO Deficiency.

  2017cites this paper
• Uncoupling of eNOS in Cardiovascular Disease

  2017cites this paper
• Obesity-induced vascular inflammation involves elevated arginase activity.

  2017cites this paper
• Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis

  2017cites this paper
• Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction

  2017cites this paper
• l-Arginine Usage in Type I Diabetes: From the Autoimmune Event to Human Dietary Supplementation

  2017cites this paper
• Arginase Inhibitors: A Rational Approach Over One Century

  2017cites this paper
• ROS Implication of eNOS Uncoupling in Cardiovascular Disease

  2017cites this paper
• The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes.

  2016cites this paper
• The eNOS signalosome and its link to endothelial dysfunction

  2016cites this paper
• Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.

  2016cites this paper
• Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases

  2016cites this paper
• Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease Patients

  2016cites this paper
• Ameliorating Endothelial Mitochondrial Dysfunction Restores Coronary Function via Transient Receptor Potential Vanilloid 1–Mediated Protein Kinase A/Uncoupling Protein 2 Pathway

  2016cites this paper
• Augmented oxidative stress and preserved vasoconstriction induced by hydrogen peroxide in coronary arteries in obesity: role of COX‐2

  2016cites this paper
• Role of Metabolites of Nitric Oxide and Arginase in the Pathogenesis of Glomerulonephritis

  2016cites this paper
• Title Adipokine Imbalance in the Pericardial Cavity of Cardiac andVascular Disease Patients

  2016cites this paper
• Papel de la arginasa en la patología cardiovascular

  2016cites this paper
• Does Inhibition of Arginase and Advanced Glycation End Products Provide a Protection Against Experimentally Induced Diabetic Nephropathy ?

  2015cites this paper
• Oxidized Low Density Lipoprotein Among the Elderly in Qinghai-Tibet Plateau

  2015cites this paper
• Tissue‐specific up‐regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus

  2015influential citation
• Arginase: an old enzyme with new tricks.

  2015cites this paper
• Nitric Oxide Synthesis in Vascular Physiology and Pathophysiology

  2015cites this paper
• Improving treatment predictors of HCV therapy and the impact of steatosis on the hepatocyte transcriptome and anti-HCV action of interferon

  2015cites this paper
• Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?

  2015cites this paper
• CALL FOR PAPERS Cardiovascular and Cerebrovascular Aging-New Mechanisms and Insights Age-related impairment of conducted dilation in human coronary arterioles

  2014cites this paper
• Exercise Training Improves Endothelial Function in Human Cardiovascular Disease - Role of Oxidative Stress 169

  2014cites this paper
• Acute beet juice ingestion improves estimates of insulin sensitivity in obese adults

  2014cites this paper
• Prevention and treatment of no-reflow phenomenon by targeting the coronary microcirculation.

  2014cites this paper
• Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.

  2014cites this paper
• Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation.

  2014cites this paper
• Peroxynitrite Disrupts Endothelial Caveolae Leading to eNOS Uncoupling and Diminished Flow-Mediated Dilation in Coronary Arterioles of Diabetic Patients

  2014cites this paper
• Development of Novel Arginase Inhibitors for Therapy of Endothelial Dysfunction

  2013cites this paper
• Arginase Promotes Skeletal Muscle Arteriolar Endothelial Dysfunction in Diabetic Rats

  2013cites this paper
• Selective Up-Regulation of Arginase-1 in Coronary Arteries of Diabetic Patients

  2013cites this paper
• Vasomotor Regulation of Coronary Microcirculation by Oxidative Stress: Role of Arginase

  2013cites this paper
• L-arginine, tetrahydrobiopterin, nitric oxide and diabetes

  2013cites this paper
• l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice

  2013cites this paper
• Arginase 1: An Unexpected Mediator of Pulmonary Capillary Barrier Dysfunction in Models of Acute Lung Injury

  2013cites this paper
• Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

  2013cites this paper
• Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.

  2013cites this paper
• Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing

  2012cites this paper
• Diabetes-induced vascular dysfunction involves arginase I.

  2012cites this paper
• Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.

  2012cites this paper
• Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway

  2012cites this paper
• Regulation and Maintenance of Vascular Tone and Patency in Cardiovascular Health and Disease

  2012cites this paper
• Efficacy of topical urea , arginine and carnosine ( Ureadin Rx Db ISDIN ) in the treatment of severe xerosis of the feet in Type 2 diabetic patients

  2012cites this paper
• Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus

  2012cites this paper
• An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, controlled trial

  2012cites this paper
• Arginase-2 Mediates Diabetic Renal Injury

  2011cites this paper